Model
Edge
RVL Pharmaceuticals
0001767593
Filing Type
4
Filing Date
8/11/2022
Updated
8/12/22, 10:07 AM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership